Simplex Trading
HZNP

Simplex Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Simplex Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-199,500
Closed -$97K – 10305
2023
Q3 		$97K Sell
199,500
-128,800
-39% -$13.8M ﹤0.01% 5117
2023
Q2 		$33.8M Buy
328,300
+271,000
+473% +$28.6M 0.03% 366
2023
Q1 		$6.25M Sell
57,300
-296,600
-84% -$32.8M 0.01% 1161
2022
Q4 		$40.3M Buy
353,900
+304,200
+612% +$25.3M 0.04% 326
2022
Q3 		$3.08M Buy
49,700
+31,600
+175% +$2.21M ﹤0.01% 1591
2022
Q2 		$1.44M Sell
18,100
-1,100
-6% -$104K ﹤0.01% 2207
2022
Q1 		$2.02M Sell
19,200
-45,400
-70% -$4.42M ﹤0.01% 2104
2021
Q4 		$6.96M Buy
64,600
+1,500
+2% +$164K 0.01% 1001
2021
Q3 		$6.09M Hold
63,100
– – 0.01% 1045
2021
Q2 		$5.91M Buy
+63,100
New +$5.81M 0.01% 1045
2021
Q1 		– Sell
-1,138
Closed -$8.32M – 10632
2020
Q4 		$8.32M Buy
1,138
+532
+88% +$39.5K 0.01% 673
2020
Q3 		$4.71M Buy
606
+491
+427% +$33.8K 0.01% 906
2020
Q2 		$639K Sell
115
-20
-15% -$856 ﹤0.01% 2629
2020
Q1 		$399K Sell
135
-94
-41% -$3.18K ﹤0.01% 2832
2019
Q4 		$828K Buy
229
+77
+51% +$2.36K ﹤0.01% 2260
2019
Q3 		$413K Buy
152
+85
+127% +$2.2K ﹤0.01% 2810
2019
Q2 		$161K Sell
67
-71
-51% -$1.8K ﹤0.01% 3692
2019
Q1 		$364K Buy
138
+128
+1,280% +$3.03K ﹤0.01% 2999
2018
Q4 		$19K Buy
10
+8
+400% +$157 ﹤0.01% 5396
2018
Q3 		$3K Sell
2
-4
-67% -$76 ﹤0.01% 7028
2018
Q2 		$9K Sell
6
-6
-50% -$91 ﹤0.01% 6440
2018
Q1 		$1K Sell
12
-595
-98% -$8.79K ﹤0.01% 5959
2017
Q4 		$3K Buy
607
+501
+473% +$7.04K ﹤0.01% 5062
2017
Q3 		$10K Sell
106
-277
-72% -$3.52K ﹤0.01% 3813
2017
Q2 		$33K Sell
383
-393
-51% -$4.89K ﹤0.01% 2800
2017
Q1 		$118K Sell
776
-322
-29% -$5.21K 0.01% 1615
2016
Q4 		$51K Buy
1,098
+497
+83% +$9.01K ﹤0.01% 2143
2016
Q3 		$53K Buy
601
+215
+56% +$4.2K ﹤0.01% 2053
2016
Q2 		$26K Buy
386
+110
+40% +$1.78K ﹤0.01% 2687
2016
Q1 		$53K Sell
276
-913
-77% -$16K ﹤0.01% 1913
2015
Q4 		$568K Buy
1,189
+664
+126% +$12.9K 0.04% 383
2015
Q3 		$270K Buy
525
+502
+2,183% +$15.9K 0.02% 744
2015
Q2 		$1K Sell
23
-230
-91% -$7.02K ﹤0.01% 4924
2015
Q1 		$8K Buy
+253
New +$4.64K ﹤0.01% 3163

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Simplex Trading's HZNP Position: Q4 2023 in Review

Simplex Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 53,301 shares — an estimated $6.17M sold.

Simplex Trading first reported a position in HZNP in Q1 2015 and held it in 25 quarters. The position peaked at $7.71M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Simplex Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 53,301 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $6.17M.
  • Simplex Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 25 quarters.
  • Simplex Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7.71M in Q2 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.